Landolfo S, Urso D, Santoro C, Batzu L, Gnoni V, Giugno A
J Neurol. 2025; 272(4):264.
PMID: 40072620
DOI: 10.1007/s00415-025-12962-z.
Ruver-Martins A, Martinez I, Holla V, de Souza B, da Silva E, Novoa D
Front Hum Neurosci. 2025; 18:1466438.
PMID: 40066073
PMC: 11891160.
DOI: 10.3389/fnhum.2024.1466438.
Rosal A, Martin S, Strafella A
Front Neurosci. 2025; 19:1515374.
PMID: 40052092
PMC: 11882537.
DOI: 10.3389/fnins.2025.1515374.
Chen M, Zhang Y, Hou L, Zhao Z, Tang P, Sun Q
NPJ Parkinsons Dis. 2025; 11(1):43.
PMID: 40050294
PMC: 11885645.
DOI: 10.1038/s41531-025-00892-6.
Khallaf M, Jaber H, Alameri M, Magdy D, Kamal H, Hassanin M
Neurol Res Int. 2025; 2025:6846267.
PMID: 40041239
PMC: 11879567.
DOI: 10.1155/nri/6846267.
Local Field Potential Biomarkers of Non-Motor Symptoms in Parkinson's Disease: Insights From the Subthalamic Nucleus in Deep Brain Stimulation.
Gobeil M, Guillemette A, Silhadi M, Charbonneau L, Bergeron D, Dominguez-Vargas A
Eur J Neurosci. 2025; 61(5):e70046.
PMID: 40040306
PMC: 11880747.
DOI: 10.1111/ejn.70046.
Quality of Life and non-motor symptoms Improvement in Parkinson's Disease through Nutritional Intervention: a Case Study.
Zanini M, Simonini M, Giusti A, Aleo G, Ripamonti S, Delbene L
J Prev Med Hyg. 2025; 65(4):E555-E562.
PMID: 40026434
PMC: 11870126.
DOI: 10.15167/2421-4248/jpmh2024.65.4.3322.
Nonmotor Symptom Changes and Their Association With Falls Among Parkinson's Disease Patients Undergoing Deep Brain Stimulation: A 1-Year Cohort Study.
Gao Y, You H, Wang J, Yao M, Li D, Sun B
CNS Neurosci Ther. 2025; 31(3):e70310.
PMID: 40022502
PMC: 11871399.
DOI: 10.1111/cns.70310.
Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: A novel mechanism for the pathogenesis of Parkinson's disease.
Liang Z, Liu W, Cao M, Cui J, Lan J, Ding Y
Theranostics. 2025; 15(6):2250-2278.
PMID: 39990232
PMC: 11840736.
DOI: 10.7150/thno.107436.
Genetic therapies for movement disorders - current status.
Sartorelli J, Ng J, Rahim A, Waddington S, Kurian M
J Neurol. 2025; 272(3):220.
PMID: 39985571
PMC: 11846774.
DOI: 10.1007/s00415-025-12940-5.
Subregion-specific associations of the basal forebrain with sleep and cognition in Parkinson's disease.
Lee J, Kim H, Ahn S, Park M, Yoo H, Lyoo C
NPJ Parkinsons Dis. 2025; 11(1):33.
PMID: 39979309
PMC: 11842645.
DOI: 10.1038/s41531-025-00880-w.
Classification of Parkinson's disease with and without dopaminergic deficiency based on non-motor symptoms and structural neuroimaging.
Ronat L, Rainville P, Monchi O, Hanganu A
Neurol Sci. 2025; .
PMID: 39969749
DOI: 10.1007/s10072-025-08045-6.
Impact of pharmacist-physician collaboration on patient outcomes in Parkinson's disease: a randomised controlled trial in tertiary care.
Techa-Angkoon P, Pitakpatapee Y, Saengphatrachai W, Srivanitchapoom P, Suansanae T
Int J Clin Pharm. 2025; .
PMID: 39945968
DOI: 10.1007/s11096-025-01883-6.
From Night to Light: A Bibliometric Analysis of the Global Research Trajectory of Sleep Disorders in Parkinson's Disease.
Shi L, Zhao X, Wu J, He C
J Multidiscip Healthc. 2025; 18:473-492.
PMID: 39902191
PMC: 11789777.
DOI: 10.2147/JMDH.S503849.
Multimodal magnetic resonance imaging studies on non-motor symptoms of Parkinson's disease.
Qi W, Niu X, Zhan X, Ren Y, He J, Li J
IBRO Neurosci Rep. 2025; 18:180-190.
PMID: 39896716
PMC: 11787613.
DOI: 10.1016/j.ibneur.2025.01.003.
CCL21-CCR7 blockade prevents neuroinflammation and degeneration in Parkinson's disease models.
Leser F, Junyor F, Pagnoncelli I, Delgado A, Medeiros I, Nobrega A
J Neuroinflammation. 2025; 22(1):31.
PMID: 39894839
PMC: 11789347.
DOI: 10.1186/s12974-024-03318-x.
Clinically probable RBD is an early predictor of malignant non-motor Parkinson's disease phenotypes.
Martinez-Nunez A, Hutchinson H, Coutinho P, Sarmento F, Srikar Lavu V, Yuan Q
NPJ Parkinsons Dis. 2025; 11(1):25.
PMID: 39875387
PMC: 11775280.
DOI: 10.1038/s41531-025-00874-8.
Unleashing creativity in people with Parkinson's disease: a pilot study of a co-designed creative arts therapy.
Spee B, de Vries N, Zeggio S, Plijnaer M, Koksma J, Duits A
J Neurol. 2025; 272(2):161.
PMID: 39849173
PMC: 11758163.
DOI: 10.1007/s00415-024-12878-0.
Aging and MPTP Sensitivity Depend on Molecular and Ultrastructural Signatures of Astroglia and Microglia in Mice Substantia Nigra.
Abhilash P, Bharti U, Rashmi S, Philip M, Raju T, Kutty B
Cell Mol Neurobiol. 2025; 45(1):13.
PMID: 39833644
PMC: 11753320.
DOI: 10.1007/s10571-024-01528-8.
Determinants of Sexual Dysfunction in Parkinson's Disease Patients: A Secondary Analysis of a Multicenter Cross-Sectional Study.
Manuli A, Maggio M, de Pasquale P, Raciti L, Filoni S, Portaro S
J Clin Med. 2025; 14(1.
PMID: 39797235
PMC: 11721904.
DOI: 10.3390/jcm14010152.